Takako Taniguchi Selected Research

Takako Taniguchi Research Topics

2	Infections 12/2018 - 02/2017
2	Peripheral Nervous System Diseases (PNS Diseases) 09/2012 - 05/2012
1	Starvation 02/2022
1	Mastitis 10/2021
1	Bovine Mastitis 10/2021
1	Rupture 11/2020
1	Bacteremia 02/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2016
1	Genomic Instability 02/2016
1	Genetic Translocation (Chromosomal Translocation) 02/2016
1	Bacterial Infections (Bacterial Infection) 01/2016
1	Dysbiosis 01/2016
1	Abscess 12/2015
1	Sepsis (Septicemia) 12/2015
1	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 12/2015
1	Mucopolysaccharidosis I (Hurler Syndrome) 09/2013
1	Pelvic Neoplasms 09/2012
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2012
1	Glucose Intolerance 01/2012
1	Obesity 01/2012

2	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 01/2016
2	Pregabalin (Lyrica)FDA Link 09/2012 - 05/2012
1	Phosphates (Orthophosphate)IBA 02/2022
1	beta-Lactamases (beta-Lactamase)IBA 10/2021
1	Cephalosporins (Cephalosporin Antibiotics)IBA 10/2021
1	ElastinIBA 11/2020
1	CollagenIBA 11/2020
1	16S Ribosomal RNAIBA 12/2018
1	Complement System Proteins (Complement)IBA 02/2017
1	Cytidine DeaminaseIBA 02/2016
1	ChromatinIBA 02/2016
1	EnzymesIBA 02/2016
1	Interleukin-1 Receptor-Associated KinasesIBA 12/2015
1	Polysaccharides (Glycans)IBA 09/2013
1	Heparitin Sulfate (Heparan Sulfate)IBA 09/2013
1	Iduronidase (alpha-L-Iduronidase)IBA 09/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2012
1	Prednisone (Sone)FDA LinkGeneric 05/2012
1	Rituximab (Mabthera)FDA Link 05/2012
1	R-CHOP protocolIBA 05/2012
1	Vincristine (Oncovin)FDA LinkGeneric 05/2012
1	Messenger RNA (mRNA)IBA 01/2012
1	Nonesterified Fatty Acids (NEFA)IBA 01/2012
1	DDTIBA 01/2012

1	Oral Administration 02/2017
1	VAP-cyclo protocol 05/2012